Ultralife (NASDAQ:ULBI) Announces Quarterly Earnings Results

Ultralife (NASDAQ:ULBI) released its quarterly earnings data on Thursday. The technology company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09), FiscalAI reports. The business had revenue of $48.27 million during the quarter, compared to analyst estimates of $56.00 million. Ultralife had a negative net margin of 3.50% and a positive return on equity of 2.75%.

Ultralife Trading Up 0.2%

NASDAQ:ULBI opened at $15.66 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.30 and a current ratio of 2.87. Ultralife has a 52 week low of $4.90 and a 52 week high of $15.69. The stock’s 50 day moving average price is $7.60 and its 200 day moving average price is $6.69. The company has a market capitalization of $260.90 million, a P/E ratio of -82.42 and a beta of 0.63.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Ultralife in a research note on Wednesday, September 9th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories.